0
61
Psychiatric News   |   January 01, 2010 
Volume 45 Number 1 page 3-3
From the President
  • Print
  • E-mail
    Recipient(s) will receive an email with a link (good for 72 hours) to 'Why is DSM-5 Being Delayed?' and do not need to have Psychiatric News account to access the content.
    Example: John Doe
    CC Me:
    Enter your valid email address. Example: jdoe@example.com
    Separate multiple email address with semi-colons (up to 5).
    's Psychiatric News: 'Why is DSM-5 Being Delayed?'
    Subject for your email.
    (Optional, message will truncate at 1000 characters)
    Copyright © in the material you requested is held by The American Psychiatric Association (unless otherwise noted). This email ability is provided as a courtesy, and by using it you agree that you are requesting the material solely for personal, non-commercial use, and that it is subject to The American Psychiatric Association's Terms of Use. The information provided in order to email this topic will not be used to send unsolicited email, nor will it be furnished to third parties. Please refer to The American Psychiatric Association's Privacy Policy for further information.
    Copyright © American Psychiatric Association. All rights reserved.
  • Share
  • Reprints
Why is DSM-5 Being Delayed?
Alan F. Schatzberg, M.D.
text A A A
View Disclosures and Other Information
©
American Psychiatric Association
Anchor for JumpAnchor for Jump
+schatzberg_0491.gif
View Large |  Download Slide(.ppt)
Add to My POL
schatzberg_0491.gif
We have recently announced a new timetable for DSM-5 (see DSM-5 Postponed Until 2013; Field Trials Scheduled for Summer). As you may remember, a few months ago we asked Dr. Carolyn Robinowitz, a past APA president, to chair the Board of Trustees DSM-5 Oversight Work Group. The work group has spent considerable time reviewing the status of the work in preparation for the new manual with the chair and vice chair of the DSM-5 Task Force, as well as with the task force and work group members. After much consideration, the task force recommended that the Board extend the timeline for development of DSM-5 and aim for its release in spring 2013 instead of 2012.
A number of issues entered into the decision. For one, there are a number of details that need to be addressed regarding the specifics of the proposed classification system, including an assessment of consistency of definitions and application of symptom dimensions. The new dimensions under consideration need to be tested in field trials that will likely take more time than initially planned. Also, we were aware that work on DSM-5 began more slowly than anticipated. One step that led to the delay was the vetting of the task force participants; it took considerably longer than expected, pushing back the start date for the overall process and obviously shortening the time for promulgation and testing in anticipation of the 2012 release date.
The draft guidelines for diagnostic criteria will be posted on the Web in the near future with a comment period of two to three months. The field trials will commence in July. Altogether it makes much more sense to lengthen the schedule to allow for sufficient discussion by task force members, as well as by investigators, clinicians, and the public. Also, the new schedule provides sufficient time for further revisions based on the results of the field trials.
Finally, the extension will permit better linking of DSM-5 to the U.S. implementation of the ICD-10-CM codes for all Medicare/Medicaid claims reporting, which are scheduled to go into effect on October 1, 2013. APA will also continue to work with the World Health Organization (WHO) to harmonize DSM-5 with the mental and behavioral disorders section of ICD-11, which WHO plans to release no sooner than 2014.
As DSM gets ready for initial comments and then field trials, I have been discussing with Dr. Darrel Regier, vice chair of the DSM Task Force, the possibility of members' playing a greater role in the collection of data that could guide future classifications as well as practice.
APA's Practice Research Network (PRN) has been in place for a number of years, and it will be involved in conducting some of the DSM-5 field trials. (The PRN is a nationwide network of psychiatrists who cooperate to collect data and conduct research studies on a variety of clinical and service-delivery issues.) Once the PRN and other DSM-5 field trials are completed and the revision is published, PRN participants could be used to identify diagnostic groups of interest and participate in genetic studies to further test the validity of these newly defined diagnostic phenotypes.
It seems to me that the members and APA need to think about going an extra mile in shaping the field and ultimately helping to improve our specialty more directly. Can we move the profession up a notch to an even more evidenced-based specialty? If you have thoughts, send me a brief e-mail at aschatzberg@psych.org.
I'd like to remind you that information about DSM-5 can be found online at Psychiatric News.
We are planning informative and interactive sessions on DSM-5 at APA's annual meeting next May. Interactive audience-response technology will be used for some of the sessions as we have been doing for FOCUS Live sessions. These should prove both informative and fun. We are looking for feedback from APA members regarding various innovations. So mark your calendars to be in New Orleans for the meeting from May 22 to 26. I look forward to seeing you all there. blacksquare[XSLExtension]

Interactive Graphics

Video

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general jounals
BMJ 2010;341:c5893-c1494.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Similar Articles
PSYCHIATRIC NEWS
Articles
Med Check
Psychiatric News 20 January 2012: Vol. 47. no. 2, pp. 30-30
Why Patients' Input Crucial to Success of Field Trials
Psychiatric News 3 December 2010: Vol. 45. no. 23, pp. 5-36
11 Large Institutions Chosen for DSM-5 Field Trials
Psychiatric News 15 October 2010: Vol. 45. no. 20, pp. 7-7
[+] View More
Copyright ©
American
Psychiatric
Association